Question
Pharmaceutical Analysis Question on Oxidation-reduction titrations
Regarding Bromocriptine, which of the following statement is TRUE‐ It is a relatively selective dopamine D2 agonist with prominent action
A. on pituitary lactotrophs (inhibit prolactin release)
B. in striatum (antiparkinsonian)
C. in CTZ (antiemetic) ATP γ K 5) 6) 7)
D. as an adjunctive treatment for type 2 DM
Choose the correct answer from the options given below:
A
A, B and D only
B
A, B and C only
C
B and D only
D
A and B only
Answer
A, B and D only
Explanation
Solution
The correct option is (A): A, B and D only